Literature DB >> 1329939

Myoepithelioma of the lacrimal gland: report of a case with spindle cell morphology.

R L Font1, A Garner.   

Abstract

The case is described of a 23-year-old female patient presenting with unilateral proptosis, headaches, and transient epiphora. Surgery revealed an encapsulated tumour composed exclusively of spindle-shaped cells within a richly vascularised myxoid stroma. Immunohistochemical staining showed focal positivity for smooth muscle actin, vimentin, and glial fibrillary acidic protein. These combined findings are interpreted as providing evidence of a myoepithelioma, which may be regarded as a monomorphic adenoma consisting solely of myoepithelial cells. To our knowledge this is only the second report of such a tumour in the lacrimal gland.

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1329939      PMCID： PMC505248          DOI： 10.1136/bjo.76.10.634

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


  8 in total

1.  S-100 protein antibodies do not label normal salivary gland myoepithelium. Histogenetic implications for salivary gland tumors.

Authors:  I Dardick; M Stratis; W R Parks; F G DeNardi; H J Kahn
Journal:  Am J Pathol       Date:  1991-03       Impact factor: 4.307

2.  An immunohistochemical study of pleomorphic adenomas of the salivary gland: glial fibrillary acidic protein-like immunoreactivity identifies a major myoepithelial component.

Authors:  R H Stead; A H Qizilbash; T Kontozoglou; A D Daya; R H Riddell
Journal:  Hum Pathol       Date:  1988-01       Impact factor: 3.466

3.  Myoepithelioma of salivary glands: report of 23 cases.

Authors:  J J Sciubba; R B Brannon
Journal:  Cancer       Date:  1982-02-01       Impact factor: 6.860

4.  Monomorphic adenomas of the salivary glands. A clinico-pathologic study of 12 cases with immunohistochemical observation.

Authors:  K J Cho; Y I Kim
Journal:  Pathol Res Pract       Date:  1989-06       Impact factor: 3.250

5.  A spindle-cell myoepithelioma of the lacrimal gland.

Authors:  J G Heathcote; J J Hurwitz; I Dardick
Journal:  Arch Ophthalmol       Date:  1990-08

6.  Immunohistologic properties of benign and malignant mixed tumor of the lacrimal gland.

Authors:  H E Grossniklaus; M F Abbuhl; I W McLean
Journal:  Am J Ophthalmol       Date:  1990-11-15       Impact factor: 5.258

Review 7.  Myoepithelioma--new concepts of histology and classification: a light and electron microscopic study.

Authors:  I Dardick; M J Thomas; A W van Nostrand
Journal:  Ultrastruct Pathol       Date:  1989 Mar-Jun       Impact factor: 1.094

8.  Distribution of S-100b protein in normal salivary glands and salivary gland tumors.

Authors:  K Hara; M Ito; J Takeuchi; S Iijima; T Endo; H Hidaka
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1983
  8 in total
  5 in total

Review 1.  Myoepithelioma of the Orbital Apex and Middle Cranial Fossa: Case Report and Review of the Literature.

Authors:  Dustin M Hayward; David Yoo; John M Lee; Elizabeth Wild; Vikram C Prabhu
Journal:  Neuroophthalmology       Date:  2014-01-28

2.  Pleomorphic Adenoma With Prominent Clear Cell Myoepithelioma Component of the Lacrimal Gland.

Authors:  Adewumi N Adekunle; Pia R Mendoza; Ted H Wojno; Hans E Grossniklaus
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2016 Jan-Feb       Impact factor: 1.746

Review 3.  Benign myoepithelioma of the lacrimal gland: report of a case.

Authors:  Andrea Bolzoni; Luca Pianta; Davide Farina; Piero Nicolai
Journal:  Eur Arch Otorhinolaryngol       Date:  2004-05-11       Impact factor: 2.503

4.  Lacrimal myoepithelial carcinoma ex recurrent pleomorphic adenoma: A clinicopathological report and review of the literature.

Authors:  Noppadol Larbcharoensub; Duangjai Pangpunyakulchai; Rangsima Aroonroch; Lojana Tuntiyatorn; Pornchai Mahaisavariya
Journal:  Mol Clin Oncol       Date:  2017-11-03

Review 5.  Rare Diseases of the Orbit.

Authors:  Ulrich Kisser; Jens Heichel; Alexander Glien
Journal:  Laryngorhinootologie       Date:  2021-04-30       Impact factor: 1.057
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.